Bal Pharma Share Price
Bal Pharma Share Price Today
As of 5 Jul 2026, Bal Pharma share price is ₹78.00. The stock opened at ₹80.55, compared to its previous close of ₹78.46. During today's trading session, Bal Pharma share price moved in the range of ₹77.55 to ₹80.99, with an average price of ₹79.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹60.00 and a high of ₹103.90. On the performance front, Bal Pharma share price has increased by 6.42% over the last six months and is down 24.75% on a year-on-year basis.
Bal Pharma Returns Calculator
Bal Pharma Shareholder Returns
Bal Pharma Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Bal Pharma Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹303.08 | ₹339.22 | ₹304.22 | ₹281.21 |
| Other Income | ₹2.20 | ₹2.85 | ₹0.94 | ₹5.15 |
| Total Revenue | ₹305.29 | ₹342.07 | ₹305.16 | ₹286.37 |
| Total Expenses | ₹300.15 | ₹333.02 | ₹300.41 | ₹277.18 |
| Profit Before Tax | ₹5.14 | ₹9.05 | ₹4.75 | ₹9.18 |
| Tax | -₹2.10 | ₹1.60 | ₹2.13 | ₹3.48 |
| Profit After Tax | ₹7.24 | ₹7.45 | ₹2.62 | ₹5.70 |
| EPS - Basic | ₹4.54 | ₹4.96 | ₹1.67 | ₹3.79 |
| EPS - Diluted | ₹4.54 | ₹4.96 | ₹1.68 | ₹3.79 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹5.14 | ₹9.05 | ₹4.75 | ₹9.18 |
| Income before WC changes | ₹29.88 | ₹31.39 | ₹26.49 | ₹26.34 |
| Change in Assets | -₹11.84 | -₹3.06 | -₹65.63 | -₹21.12 |
| Change in Liabilities | ₹4.35 | -₹0.98 | ₹38.11 | ₹22.78 |
| Change in WC | -₹7.49 | -₹4.04 | -₹27.53 | ₹1.66 |
| Cash flow from Operations | ₹20.32 | ₹22.81 | -₹1.54 | ₹26.80 |
| Cash flow from Investing | -₹14.92 | -₹18.89 | -₹22.18 | -₹9.48 |
| Cash flow from Financing | -₹7.84 | -₹1.21 | ₹24.09 | -₹17.22 |
| Total Cash Flow | -₹2.44 | ₹2.71 | ₹0.37 | ₹0.09 |
| Cash (Start of the year) | ₹4.20 | ₹1.49 | ₹1.11 | ₹1.02 |
| Cash (End of the year) | ₹1.75 | ₹4.20 | ₹1.49 | ₹1.11 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹100.82 | ₹85.68 | ₹85.02 | ₹75.96 |
| Current Assets | ₹234.87 | ₹234.16 | ₹228.16 | ₹184.57 |
| Total Assets | ₹335.69 | ₹319.84 | ₹313.17 | ₹260.53 |
| Current Liabilities | ₹219.50 | ₹203.06 | ₹209.33 | ₹165.64 |
| Net Current Asset | ₹15.37 | ₹31.10 | ₹18.82 | ₹18.93 |
| Non-Current Liabilities | ₹38.79 | ₹44.81 | ₹40.14 | ₹36.40 |
| Equity Capital | ₹77.40 | ₹71.97 | ₹63.70 | ₹58.49 |
| Total Equity & Liabilities | ₹335.69 | ₹319.84 | ₹313.17 | ₹260.53 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹302.50 | ₹338.54 | ₹303.10 | ₹280.37 |
| Other Income | ₹2.15 | ₹2.30 | ₹2.19 | ₹6.49 |
| Total Revenue | ₹304.65 | ₹340.84 | ₹305.29 | ₹286.86 |
| Total Expenses | ₹298.91 | ₹331.52 | ₹296.74 | ₹274.80 |
| Profit Before Tax | ₹5.73 | ₹9.32 | ₹8.55 | ₹12.06 |
| Tax | -₹2.07 | ₹1.59 | ₹2.42 | ₹3.48 |
| Profit After Tax | ₹7.80 | ₹7.73 | ₹6.13 | ₹8.58 |
| EPS - Basic | ₹4.89 | ₹5.13 | ₹3.90 | ₹5.79 |
| EPS - Diluted | ₹4.89 | ₹5.13 | ₹3.94 | ₹5.67 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹5.73 | ₹9.32 | ₹8.55 | ₹12.06 |
| Income before WC changes | ₹30.34 | ₹30.85 | ₹27.40 | ₹26.04 |
| Change in Assets | -₹12.58 | ₹2.56 | -₹42.56 | -₹21.43 |
| Change in Liabilities | ₹4.63 | -₹0.32 | ₹21.04 | ₹27.07 |
| Change in WC | -₹7.95 | ₹2.23 | -₹21.52 | ₹5.64 |
| Cash flow from Operations | ₹20.31 | ₹28.54 | ₹5.38 | ₹30.57 |
| Cash flow from Investing | -₹14.90 | -₹18.84 | -₹22.08 | -₹13.43 |
| Cash flow from Financing | -₹7.83 | -₹6.94 | ₹17.12 | -₹17.22 |
| Total Cash Flow | -₹2.42 | ₹2.76 | ₹0.42 | -₹0.08 |
| Cash (Start of the year) | ₹4.06 | ₹1.30 | ₹0.81 | ₹0.89 |
| Cash (End of the year) | ₹1.64 | ₹4.06 | ₹1.23 | ₹0.81 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹102.91 | ₹87.68 | ₹77.75 | ₹71.56 |
| Current Assets | ₹247.65 | ₹246.55 | ₹269.95 | ₹218.20 |
| Total Assets | ₹350.56 | ₹334.23 | ₹347.70 | ₹289.76 |
| Current Liabilities | ₹213.46 | ₹197.13 | ₹212.15 | ₹166.10 |
| Net Current Asset | ₹34.19 | ₹49.41 | ₹57.80 | ₹52.10 |
| Non-Current Liabilities | ₹38.28 | ₹44.25 | ₹39.52 | ₹36.34 |
| Equity Capital | ₹98.82 | ₹92.84 | ₹96.03 | ₹87.32 |
| Total Equity & Liabilities | ₹350.56 | ₹334.23 | ₹347.70 | ₹289.76 |
About Bal Pharma
Bal Pharma Limited is a pharmaceutical company engaged in the manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It specializes in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers a range of APIs including antihistamine, platelet inhibitor, anti-diabetic, anticonvulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers a range of formulations covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmics, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.
Bal Pharma Financial Highlights
- Revenue: Bal Pharma reported revenue of ₹313.59 crore in FY26 vs ₹305.28 crore in FY25. It showed an increase of 2.72% on a yearly basis.
- Operating Profit: Bal Pharma reported an operating profit of ₹5.93 crore in FY26 vs ₹5.14 crore in FY25. It showed an increase of 15.37% on a year-on-year basis.
- Net Profit: Bal Pharma reported a net profit of ₹6.32 crore in FY26 vs ₹7.24 crore in FY25. It showed a decrease of 12.71% on a yearly basis.
Bal Pharma Quarterly Result Highlights
- Bal Pharma reported revenue of ₹83.84 crore in Mar 2026, compared with ₹88.02 crore in Dec 2025, representing a decrease of 4.75% on a quarter-on-quarter (QoQ) basis.
- Bal Pharma reported an operating profit of ₹3.22 crore in Mar 2026, compared with ₹1.79 crore in Dec 2025, representing an increase of 79.89% on a quarter-on-quarter (QoQ) basis.
- Bal Pharma reported a profit of ₹3.60 crore in Mar 2026, compared with ₹1.79 crore in Dec 2025, reflecting an increase of 101.12% on a QoQ basis.
- The earnings per share (EPS) of Bal Pharma stood at ₹4.54 during Mar 2026.
Similar Stocks
FAQs on Bal Pharma Share Price
What is Bal Pharma share price today?
Bal Pharma share price is ₹78.00 as on 03 Jul, 2026, 15:29 IST.
How has the Bal Pharma share price performed in the past?
In the last 1 year, Bal Pharma delivered a return of -24.75%. The Bal Pharma share price hit a high of ₹103.90 and low of ₹60.00.
How much is the Mutual Fund shareholding in Bal Pharma shares?
The Mutual Fund Shareholding in Bal Pharma was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Bal Pharma shares ?
The 52-week high and low of Bal Pharma share is ₹103.90 and ₹60.00 as of 03 Jul, 2026.
What is the market cap of Bal Pharma?
The market capitalisation of Bal Pharma is ₹125.11 Crores as on 03 Jul, 2026.
What are the stock symbols of Bal Pharma?
The stock symbol of Bal Pharma is BALPHARMA on the NSE, 524824 on the BSE, and the ISIN is INE083D01012.
What was yesterday's closing price of Bal Pharma shares ?
Bal Pharma shares closed yesterday at ₹78.46 on NSE & ₹78.58 on BSE
How to buy Bal Pharma shares?
To buy Bal Pharma shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Bal Pharma shares on Holidays?
No, shares of Bal Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Bal Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Bal Pharma?
The PE and PB ratio of Bal Pharma is 19.79 and 1.52 respectively, as on 03 Jul, 2026, 15:29 IST.